tirzepatide weight loss name Ozempic® (semaglutide) and Mounjaro™ (tirzepatide), a major breakthrough for the treatment of obesity Users of Zepbound or Mounjaro

Genetic variants in GLP-1 pathway genes are likely contributors which is why a generic "eat less, move more" prescription misses the mark for so many Indians

ZKA, RV, JS-L and PV had access to all data used in the study

This is challenging when appetite is suppressed

The pivotal SURMOUNT-1 trial that established tirzepatide's weight-loss efficacy capped doses at 5, 10, and 15 mg weekly and showed 20.9% mean body-weight reduction at 15 mg over 72 weeks (Jastreboff et al., 2022)

Avantika Waring, MD, is the Chief Medical Officer at 9amHealth, bringing over fifteen years of clinical and leadership experience

Find articles by Helms, H